GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » Total Current Liabilities

Cryo-Cell International (FRA:ZCY) Total Current Liabilities : €17.96 Mil (As of Feb. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Cryo-Cell International's total current liabilities for the quarter that ended in Feb. 2024 was €17.96

Cryo-Cell International Total Current Liabilities Historical Data

The historical data trend for Cryo-Cell International's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Total Current Liabilities Chart

Cryo-Cell International Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.96 13.89 18.46 19.11 19.28

Cryo-Cell International Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.66 18.13 17.02 19.28 17.96

Cryo-Cell International Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Cryo-Cell International's Total Current Liabilities for the fiscal year that ended in Nov. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=7.711+1.491
+Other Current Liabilities+Current Deferred Liabilities
=1.109+8.967
=19.28

Cryo-Cell International's Total Current Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=6.409+2.22
+Other Current Liabilities+Current Deferred Liabilities
=0.618+8.709
=17.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Cryo-Cell International Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryo-Cell International (FRA:ZCY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » Total Current Liabilities
Comparable Companies
JRSS PIII PHCI TOI CCM AONC ATIP AMS CLRD HLYK HCA SAU:4013 XTER:FRE SZSE:300015 THC BSP:RDOR3 BKK:BDMS XTER:FME DVA UHS
Traded in Other Exchanges
CCEL:USA
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Website
https://www.cryo-cell.com
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Cryo-Cell International (FRA:ZCY) Headlines

No Headlines